Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board

"It's an honor to have Dr. Langer join our SAB," commented Michael M. Lipp, PhD, Chief Technology Officer of Decoy. "Having worked in Dr. Langer's lab and at start-up companies that were founded on innovations arising from his lab, I've seen first-hand the impact he brings in discovering transformational therapies and advancing their development. We are confident that Dr. Langer's tremendous experience and know-how will provide invaluable support as we use our proprietary IMP3ACT platform to advance a portf ...